James H. Meador-Woodruff, M.D., was elected by the American College of Neuropsychopharmacology to a three-year term on its council, beginning in December 2014.
UAB neuroscientists are pursuing discoveries with the potential to reshape understanding of the brain.
The University of Alabama System Board of Trustees approved the establishment of the James K. Kirklin, M.D., Endowed Lectureship and other faculty appointments during its Nov. 8 meeting.
UAB mental health professionals will join former Surgeon General David Satcher, M.D., Ph.D., in a program aimed at recovery and resilience after the trauma of the 16th Street Church bombing.
For the past two years, Tolu Aduroja, M.D., M.P.H., has traveled to Ibadan, Nigeria in the fall to offer free medical care.
Investigators at UAB and colleagues at other universities have launched a study of a new, low-strength magnetic field as a potential therapy for depression.
Investigators studying a long-acting injectable formulation of aripiprazole, a partial dopamine agonist.
Yogesh Dwivedi, Ph.D., will join UAB in August as a professor and director of translational neuroscience in the Mood Disorders Program.
Researchers say ketamine appears to work on depression by blocking the neurotransmitter glutamate from binding to the NMDA receptor on neurons.